Heart Failure NYHA Class I
7
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Promoting Well-being and Health in Heart Failure
Cardio-fistular Recirculation in Patients With Chronic Heart Failure and Preserved Left Ventricle Ejection Fraction
Cognitive Intervention to Improve Memory in Heart Failure Patients
Future Patient - Telerehabilitation of Heart Failure Patients
Cycle Ergometer Training and Heart Failure on Heart Rate Recovery and Mind Fullness
HEart fAiluRe evaluaTion Questionnaire
Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2